MMI Advances REMIND Alzheimer’s Study After FDA IDE Approval
JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...
Investigational Device Exemption
Advertisement
FlyteHealth Expands Medicare Care Through CMS Platform
NEW CANAAN, Conn., July 28, 2026 FlyteHealth has achieved General Availability within the Centers for Medicare & Medicaid Services...
Aqua Medical Treats First U.S. Patient in Diabetes Trial
PLEASANTON, Calif., July 28, 2026 Aqua Medical, Inc. has achieved a major clinical milestone with the successful treatment of...
Vivos Receives FDA IDE Approval for RadioGel Trial
KENNEWICK, Wash., July 6, 2026 Vivos Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the...
Matter Bio Wins FDA IND Clearance for LM-LLO-TT Trial
SAN FRANCISCO, June 10, 2026 Matter Bio has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Advertisements
SpinaFX Wins FDA IDE for Triojection Lumbar Disc Therapy
TORONTO, June 9, 2026 SpinaFX Medical has achieved a major regulatory milestone after receiving U.S. Food and Drug Administration...
EndoZip™ Begins Pivotal Trial to Advance Automated ESG in U.S.
CAESAREA, Israel, Dec. 10, 2025 — Nitinotes Ltd., an early commercial-stage medical technology company developing fully automated endoluminal suturing...
Advertisement
